• Spencer Kobren Tells The Bald Truth To The Washington Post

    Washington Post reporter Cathy Alter, documents one man’s effort to find a solution to his hair loss through non-surgical hair replacement, and discuses the emotional aspects of hair loss that society still seems to overlook. The article titled “What Lies Beneath,” also discusses our inability to mourn the loss of our hair due to society’s perception of hair loss and hair replacement.

    It’s a fraternity that no one wants to belong to,” says Spencer Kobren, founder of the American Hair Loss Association. “It’s almost like ‘Fight Club.’ The first rule about our club is: Don’t talk about our club.


    David Maciukiewicz sits in a leather swivel chair and regards himself in the mirror. He rotates slightly into profile and pats down some errant hair at his temple. He moves his hand slowly around the perimeter of his head, fluffing up certain sections and smoothing down others, until he’s completely satisfied with the condition of his coif. The result: a thick helmet with slightly poofed bangs.

    “Ready?” asks a man in a white lab coat who is standing behind Maciukiewicz and holding a long black comb.
    “I’ll do it myself,” he responds.

    Leaning into the mirror, Maciukiewicz grabs the hair at the top of his head and in one fluid jerk, like he’s plucking the top off a jack-o’-lantern, removes it entirely. Before placing it in the technician’s outreached hands, Maciukiewicz brings the hair to his face and, impulsively, sniffs it.[…]

    Read Full Article: What Lies Beneath

  • HairDX Hair Loss Test Now Sold In Japan

    It’s been just about a year since we first reported on HairDX, the breakthrough DNA test that looks for a genetic variant found in most bald men. HairDX has certainly helped American hair loss sufferers make better, more informed choices when considering treating their hair loss. As of this month, Japanese men and women will be able to test for their genetic predisposition for hair loss as well.

    PharmaGenoma, Inc., is the first company ever to introduce a test of this kind. The company announced its exclusive agreement with Aderans Company Limited of Tokyo. This breakthrough test will be available March 1, 2009 in Japan and sold as a HairDX test collection kit. The kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a Class 1 medical device.

    The simple and accurate genetic test provides clear information that is easy to understand. HairDX analyzes the likelihood of a man or woman developing Androgenetic Alopecia, the most common type of hair loss.

     “Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of Aderans Co. Ltd. Read more ›

  • Hair Loss Pill Fights Cancer

    Looks like Finasteride, sold as Propecia to combat male pattern hair loss, has been clinically proven to help prevent prostate cancer but there are still questions left to be answered about the drug. 

    This is the first medication that has demonstrated the ability to help prevent prostate disease, experts said. The American Cancer Society notes that more than 186,000 men are diagnosed with prostate cancer each year. Nearly 29,000 die of it. That is why such special attention is being paid to Finasteride.

    While previous studies show that Finasteride reduces the overall likelihood of getting prostate cancer by 25%, some doctors are concerned that Finasteride may increase the risk of developing the deadliest types of tumors. However, the most recent analyses have nearly dismissed these worries. According to the American Society of Clinical Oncology and the American Urological Association, the drug’s benefits are a good enough reason for men to discuss Finasteride with their doctors. Read more ›



Enter your email address:


"Spencer Kobren's nationally syndicated show "The Bald Truth" has a dedicated listenership that would have Rush Limbaugh pulling his hair out in envy." --Pittsburgh Tribune-Review.


BaldTruthTalk Forums